search again

ASXL1 Gene Test for Bone Marrow Disorders

Nationwide rates for HCPCS 81175

A laboratory test that examines the ASXL1 gene in a blood or bone marrow sample for changes associated with disorders of the bone marrow, including myelodysplastic syndromes and certain leukemias. Findings help confirm a diagnosis and give a sense of how the disease is likely to behave. Results are read alongside the blood counts, marrow findings, and other testing.

Rates data updated July 2026.

Facilitymedian $1,047 · 10th–90th $550$3,0200%10%20%10th90th$1,047Professionalmedian $575 · 10th–90th $302$1,2880%20%10th90th$575$1.0$10.0$100.0$1.0K$10.0K$100.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$537.03
Median
$1,096.48
Typical High
$2,951.21
Aetna
Setting
Professional
Modifier
Global
Typical Low
$426.58
Median
$549.54
Typical High
$1,288.25
BCBS
Setting
Facility
Modifier
Global
Typical Low
$602.56
Median
$912.01
Typical High
$3,090.30
BCBS
Setting
Professional
Modifier
Global
Typical Low
$281.84
Median
$398.11
Typical High
$1,318.26
Cigna
Setting
Facility
Modifier
Global
Typical Low
$501.19
Median
$1,380.38
Typical High
$2,951.21
Cigna
Setting
Professional
Modifier
Global
Typical Low
$323.59
Median
$776.25
Typical High
$1,621.81
United
Setting
Facility
Modifier
Global
Typical Low
$316.23
Median
$676.08
Typical High
$812.83
United
Setting
Professional
Modifier
Global
Typical Low
$281.84
Median
$407.38
Typical High
$912.01